Clinical Trial Update: Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 trial by the University of Oxford evaluating whether Schistosoma mansoni infection alters the immune response to the MVA85A tuberculosis vaccine in BC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED